market existing drugs new indications i heard npr marketplace earlier pfizer current strategy focus getting current product line marketed indications rather developing newer meds kind admission bother anyone pharmagossip written issue occasion pointing long drug industry run around circles research money needs start going toward developing new meds add significant benefit beyond existing products rather creating me new drug classes actually add little existing treatments remember hear phrma waxing poetic much money spent r large chunk money going conduct studies showing existing product roughly effective drugs treating condition kind research generally little improve patient outcomes